Apanel of outside experts on Thursday recommended the Food and Drug Administration issue an emergency use authorization to the Covid-19 vaccine being developed by Pfizer and BioNTech, a vaccine that appeared to be highly efficacious in a Phase 3 clinical trial. The 17-4 vote came after a long day in which members of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC, discussed a wide range of issues related to the vaccine, including concerns about vaccinating people with severe allergies and 16- and 17-year-olds, as well as issues regarding vaccination during pregnancy or lactation. Although the FDA does not have to follow the panel’s recommendation, it is widely expected to do so.


(CC BY 2.0), Flickr, NIAID

Read more STAT…

The post FDA advisory panel endorses Pfizer/BioNTech Covid-19 vaccine appeared first on Healthier Environment Living Program.